FDA Application
-
NDC Search Results on Active Ingredient: fluticasone propionate
Click on Active Ingredient to view the label.
| Ingredient Name | NDC | Company Name | Application Number or Regulatory Citation | Product Type | Marketing Category |
|---|---|---|---|---|---|
| FLUTICASONE PROPIONATE | 50090-6058-0 | A-S Medication Solutions | NDA021433 | HUMAN PRESCRIPTION DRUG | NDA authorized generic |
| FLUTICASONE PROPIONATE | 50090-6419-1 | A-S Medication Solutions | ANDA076504 | HUMAN PRESCRIPTION DRUG | ANDA |
| FLUTICASONE PROPIONATE | 50090-6823-0 | A-S Medication Solutions | ANDA207957 | HUMAN OTC DRUG | ANDA |
| FLUTICASONE PROPIONATE | 50090-7076-0 | A-S Medication Solutions | NDA020833 | HUMAN PRESCRIPTION DRUG | NDA authorized generic |
| FLUTICASONE PROPIONATE | 50383-700-09 | Akorn | ANDA077570 | HUMAN PRESCRIPTION DRUG | ANDA |
| FLUTICASONE PROPIONATE | 50383-700-16 | Akorn | ANDA077570 | HUMAN PRESCRIPTION DRUG | ANDA |
| FLUTICASONE PROPIONATE | 50383-968-16 | Akorn | ANDA208024 | HUMAN OTC DRUG | ANDA |
| FLUTICASONE PROPIONATE | 50383-968-18 | Akorn | ANDA208024 | HUMAN OTC DRUG | ANDA |
| FLUTICASONE PROPIONATE | 50383-968-36 | Akorn | ANDA208024 | HUMAN OTC DRUG | ANDA |
| FLUTICASONE PROPIONATE | 50383-968-37 | Akorn | ANDA208024 | HUMAN OTC DRUG | ANDA |
| FLUTICASONE PROPIONATE | 50383-968-38 | Akorn | ANDA208024 | HUMAN OTC DRUG | ANDA |
| FLUTICASONE PROPIONATE | 50436-2640-1 | Unit Dose Services | ANDA078492 | HUMAN PRESCRIPTION DRUG | ANDA |
| FLUTICASONE PROPIONATE | 50436-9992-1 | Unit Dose Services | ANDA077570 | HUMAN PRESCRIPTION DRUG | ANDA |
| FLUTICASONE PROPIONATE | 50594-319-02 | Big Lots Stores, Inc. | ANDA207957 | HUMAN OTC DRUG | ANDA |
| FLUTICASONE PROPIONATE | 50594-319-08 | Big Lots Stores, Inc. | ANDA207957 | HUMAN OTC DRUG | ANDA |
| FLUTICASONE PROPIONATE | 51316-074-25 | CVS PHARMACY, INC | ANDA208024 | HUMAN OTC DRUG | ANDA |
| FLUTICASONE PROPIONATE | 51316-074-34 | CVS PHARMACY, INC | ANDA208024 | HUMAN OTC DRUG | ANDA |
| FLUTICASONE PROPIONATE | 51316-074-35 | CVS PHARMACY, INC | ANDA208024 | HUMAN OTC DRUG | ANDA |
| FLUTICASONE PROPIONATE | 51316-074-54 | CVS PHARMACY, INC | ANDA208024 | HUMAN OTC DRUG | ANDA |
| FLUTICASONE PROPIONATE | 51672-4095-1 | Taro Pharmaceuticals U.S.A., Inc. | ANDA077145 | HUMAN PRESCRIPTION DRUG | ANDA |
| FLUTICASONE PROPIONATE | 51672-4095-2 | Taro Pharmaceuticals U.S.A., Inc. | ANDA077145 | HUMAN PRESCRIPTION DRUG | ANDA |
| FLUTICASONE PROPIONATE | 51672-4095-3 | Taro Pharmaceuticals U.S.A., Inc. | ANDA077145 | HUMAN PRESCRIPTION DRUG | ANDA |
| FLUTICASONE PROPIONATE | 51672-4095-5 | Taro Pharmaceuticals U.S.A., Inc. | ANDA077145 | HUMAN PRESCRIPTION DRUG | ANDA |
| FLUTICASONE PROPIONATE | 53002-1401-1 | RPK Pharmaceuticals, Inc. | NDA021433 | HUMAN PRESCRIPTION DRUG | NDA authorized generic |
| SALMETEROL XINAFOATE; FLUTICASONE PROPIONATE | 53002-1568-1 | RPK Pharmaceuticals, Inc. | NDA021077 | HUMAN PRESCRIPTION DRUG | NDA authorized generic |
| FLUTICASONE PROPIONATE | 53002-2294-1 | RPK Pharmaceuticals, Inc. | NDA021433 | HUMAN PRESCRIPTION DRUG | NDA authorized generic |
| FLUTICASONE PROPIONATE | 53002-2310-1 | RPK Pharmaceuticals, Inc. | NDA021433 | HUMAN PRESCRIPTION DRUG | NDA authorized generic |
| FLUTICASONE PROPIONATE | 53002-7691-1 | RPK Pharmaceuticals, Inc. | ANDA077538 | HUMAN PRESCRIPTION DRUG | ANDA |
| FLUTICASONE PROPIONATE | 53002-7693-1 | RPK Pharmaceuticals, Inc. | ANDA078492 | HUMAN PRESCRIPTION DRUG | ANDA |
| FLUTICASONE PROPIONATE | 53217-164-01 | Aidarex Pharmaceuticals LLC | ANDA077055 | HUMAN PRESCRIPTION DRUG | ANDA |
| 1-30 | 31-60 | 61-90 | 91-120 | 121-150 | 151-180 | 181-210 | 211-240 | 241-270 | 271-300 |
| 301-330 | 331-360 | 361-390 | 391-417 |
-
